Glucagon-like peptide (GLP-1) receptor agonists like semaglutide and liraglutide are already … More
The talk of the town at this year’s American Society of Addiction Medicine (ASAM) Annual Conference was GLP-1 receptor agonists (GLP-1 RAs), generally known as medications to treat obesity. Mainstream media appears to mirror this trend as nearly every other radio and television ad seemingly involves a weight loss…
Continue Reading
News Source: www.forbes.com
Leave a Reply